Abstract

Lung cancer initiation and progression driven by epidermal growth factor receptor (EGFR) mutation has been extensively studied in the past decade. EGFR mutation is a significant driver of tumorigenesis and inflammation. This receptor is directly related to many downstream pathways that influence cancer metabolism and the ability of tumor cells to adapt to changes in the tumor microenvironment. Our study finds that cancer metabolism plays a large role in the progression of tumorigenesis in early-stage lung cancer. Kynurenine (KYN), a metabolite from the tryptophan pathway, was found to be highly upregulated in early-stage, EGFR-mutation driven lung cancer by metabolomic analysis. The connection between EGFR mutation and the upregulation of kynurenine remains largely unknown. Our data also shows that a significant pathway related to precancer initiation is systemic lupus erythematosus (SLE). We hypothesize that kynurenine may have a dual role in early tumorigenesis. We propose that high levels of kynurenine may be a part of metabolic reprogramming caused by genetic regulation of indoleamine 2,3-dioxygenase 1/2 (IDO1/2). Additionally, kynurenine may be used as a signaling molecule in the tumor microenvironment to allow the early tumor cells to evade immune detection. Our study has implications for the early treatment of lung cancer and provides insight into a potential clinical target in the tryptophan pathway.

Notes

If this is your thesis or dissertation, and want to learn how to access it or for more information about readership statistics, contact us at STARS@ucf.edu

Graduation Date

2023

Semester

Summer

Advisor

Zhang, Wencai

Degree

Master of Science (M.S.)

College

College of Medicine

Department

Burnett School of Biomedical Sciences

Degree Program

Biotechnology

Identifier

CFE0009782; DP0027890

URL

https://purls.library.ucf.edu/go/DP0027890

Language

English

Release Date

August 2028

Length of Campus-only Access

5 years

Access Status

Masters Thesis (Campus-only Access)

Location

College of Medicine

Restricted to the UCF community until August 2028; it will then be open access.

Share

COinS